115 related articles for article (PubMed ID: 38890647)
1. Genetic characteristics of chromosomally integrated carbapenemase gene (bla
Wang Q; Dong K; Liu X; Li W; Bian Q
BMC Microbiol; 2024 Jun; 24(1):216. PubMed ID: 38890647
[TBL] [Abstract][Full Text] [Related]
2. First report of bla
Leulmi Z; Kandouli C; Mihoubi I; Benlabed K; Lezzar A; Rolain JM
J Glob Antimicrob Resist; 2019 Mar; 16():125-129. PubMed ID: 30217548
[TBL] [Abstract][Full Text] [Related]
3. A Novel SXT/R391 Integrative and Conjugative Element Carries Two Copies of the
He J; Sun L; Zhang L; Leptihn S; Yu Y; Hua X
mSphere; 2021 Aug; 6(4):e0058821. PubMed ID: 34378988
[TBL] [Abstract][Full Text] [Related]
4. Study of the molecular characteristics and homology of carbapenem-resistant
Liu M; Li D; Jia W; Ma J; Zhao X
J Med Microbiol; 2023 Jan; 72(1):. PubMed ID: 36748625
[No Abstract] [Full Text] [Related]
5. Genomic characterisation of a Proteus mirabilis clinical isolate from China carrying bla
Sun L; Xu J; He F
J Glob Antimicrob Resist; 2019 Dec; 19():317-319. PubMed ID: 31698108
[TBL] [Abstract][Full Text] [Related]
6. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region.
Siebor E; Neuwirth C
J Antimicrob Chemother; 2011 Nov; 66(11):2513-20. PubMed ID: 21846670
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate.
Girlich D; Bonnin RA; Bogaerts P; De Laveleye M; Huang DT; Dortet L; Glaser P; Glupczynski Y; Naas T
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855079
[TBL] [Abstract][Full Text] [Related]
8. Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.
Protonotariou E; Poulou A; Politi L; Meletis G; Chatzopoulou F; Malousi A; Metallidis S; Tsakris A; Skoura L
Int J Antimicrob Agents; 2020 Aug; 56(2):106060. PubMed ID: 32574790
[TBL] [Abstract][Full Text] [Related]
9. Dissemination of Multidrug-Resistant Proteus mirabilis Clones Carrying a Novel Integron-Borne
Ramos AC; Cayô R; Carvalhaes CG; Jové T; da Silva GP; Sancho FMP; Chagas-Neto T; Medeiros EAS; Gales AC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158274
[TBL] [Abstract][Full Text] [Related]
10. Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community.
Potron A; Hocquet D; Triponney P; Plésiat P; Bertrand X; Valot B
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962345
[TBL] [Abstract][Full Text] [Related]
11. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant Proteus mirabilis isolates carrying bla
Kang Q; Wang X; Zhao J; Liu Z; Ji F; Chang H; Yang J; Hu S; Jia T; Wang X; Tang J; Dong G; Hu G; Wang J; Zhang Y; Qin J; Wang C
Integr Zool; 2021 Nov; 16(6):798-809. PubMed ID: 33289300
[TBL] [Abstract][Full Text] [Related]
13. First report of an OXA-48-producing multidrug-resistant Proteus mirabilis strain from Gaza, Palestine.
Chen L; Al Laham N; Chavda KD; Mediavilla JR; Jacobs MR; Bonomo RA; Kreiswirth BN
Antimicrob Agents Chemother; 2015 Jul; 59(7):4305-7. PubMed ID: 25896692
[TBL] [Abstract][Full Text] [Related]
14. Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt.
ElTaweel M; Said HS; Barwa R
Ann Clin Microbiol Antimicrob; 2024 May; 23(1):46. PubMed ID: 38790053
[TBL] [Abstract][Full Text] [Related]
15. Integration of the blaNDM-1 carbapenemase gene into Proteus genomic island 1 (PGI1-PmPEL) in a Proteus mirabilis clinical isolate.
Girlich D; Dortet L; Poirel L; Nordmann P
J Antimicrob Chemother; 2015 Jan; 70(1):98-102. PubMed ID: 25239462
[TBL] [Abstract][Full Text] [Related]
16. Increased Resistance to Carbapenems in
Bontron S; Poirel L; Kieffer N; Savov E; Trifonova A; Todorova I; Kueffer G; Nordmann P
Microb Drug Resist; 2019 Jun; 25(5):663-667. PubMed ID: 30676261
[No Abstract] [Full Text] [Related]
17. Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13.
Schultz E; Haenni M; Mereghetti L; Siebor E; Neuwirth C; Madec JY; Cloeckaert A; Doublet B
J Antimicrob Chemother; 2015 Sep; 70(9):2543-6. PubMed ID: 26066582
[TBL] [Abstract][Full Text] [Related]
18. Unveiling the genetic architecture and transmission dynamics of a novel multidrug-resistant plasmid harboring bla
Han D; Ma S; He C; Yang Y; Li P; Lu L
BMC Microbiol; 2024 May; 24(1):178. PubMed ID: 38783210
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal integration and location on IncT plasmids of the blaCTX-M-2 gene in Proteus mirabilis clinical isolates.
Harada S; Ishii Y; Saga T; Kouyama Y; Tateda K; Yamaguchi K
Antimicrob Agents Chemother; 2012 Feb; 56(2):1093-6. PubMed ID: 22106217
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis.
Mata C; Navarro F; Miró E; Walsh TR; Mirelis B; Toleman M
J Antimicrob Chemother; 2011 Oct; 66(10):2266-70. PubMed ID: 21752830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
